The biotechnology sector is showing renewed signs of life, with improving funding conditions, increased M&A activity and a stronger focus on companies advancing high-quality clinical programs. As sentiment shifts back towards innovation and execution, the next generation of drug developers could present compelling opportunities for long-term investors. "Taking on a challenge is a lot like riding a horse; if you're comfortable while you're doing it, you're probably doing it wrong." — Ted Lasso ...

When this writer first set about a career in finance we were tasked with uncovering how much each ASX energy company was worth, with little

Below we try to summarise the key points around demographics for the two most populous nations on the planet; China and India, as well as Au